Invesco’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.92M | Buy |
547,360
+98,141
| +22% | +$402K | ﹤0.01% | 2564 |
|
|
2025
Q4 | $1.51M | Buy |
449,219
+82,687
| +23% | +$215K | ﹤0.01% | 2729 |
|
|
2025
Q3 | $480K | Buy |
366,532
+44,385
| +14% | +$45.9K | ﹤0.01% | 3233 |
|
|
2025
Q2 | $231K | Buy |
322,147
+46,894
| +17% | +$36.8K | ﹤0.01% | 3475 |
|
|
2025
Q1 | $405K | Sell |
275,253
-246,735
| -47% | -$588K | ﹤0.01% | 3242 |
|
|
2024
Q4 | $2.31M | Sell |
521,988
-5,706
| -1% | -$23.2K | ﹤0.01% | 2557 |
|
|
2024
Q3 | $2.17M | Sell |
527,694
-1,139,072
| -68% | -$6.12M | ﹤0.01% | 2572 |
|
|
2024
Q2 | $10.9M | Buy |
1,666,766
+1,149,803
| +222% | +$8.13M | ﹤0.01% | 1752 |
|
|
2024
Q1 | $4.5M | Sell |
516,963
-41,064
| -7% | -$498K | ﹤0.01% | 2300 |
|
|
2023
Q4 | $6.38M | Sell |
558,027
-486,694
| -47% | -$4.81M | ﹤0.01% | 2109 |
|
|
2023
Q3 | $10.1M | Sell |
1,044,721
-622,111
| -37% | -$6.1M | ﹤0.01% | 1755 |
|
|
2023
Q2 | $17.7M | Sell |
1,666,832
-91,962
| -5% | -$988K | ﹤0.01% | 1431 |
|
|
2023
Q1 | $18.5M | Buy |
1,758,794
+55,584
| +3% | +$623K | 0.01% | 1390 |
|
|
2022
Q4 | $21.1M | Buy |
1,703,210
+27,682
| +2% | +$314K | 0.01% | 1347 |
|
|
2022
Q3 | $17.4M | Buy |
1,675,528
+465,328
| +38% | +$5.28M | 0.01% | 1415 |
|
|
2022
Q2 | $14M | Buy |
1,210,200
+529,734
| +78% | +$6.24M | ﹤0.01% | 1611 |
|
|
2022
Q1 | $8.56M | Sell |
680,466
-81,716
| -11% | -$937K | ﹤0.01% | 2057 |
|
|
2021
Q4 | $8.89M | Buy |
762,182
+60,905
| +9% | +$747K | ﹤0.01% | 2074 |
|
|
2021
Q3 | $9.16M | Sell |
701,277
-12,924
| -2% | -$167K | ﹤0.01% | 2053 |
|
|
2021
Q2 | $9.19M | Sell |
714,201
-212,325
| -23% | -$2.43M | ﹤0.01% | 2102 |
|
|
2021
Q1 | $10.4M | Buy |
926,526
+344,567
| +59% | +$3.64M | ﹤0.01% | 1925 |
|
|
2020
Q4 | $6.63M | Sell |
581,959
-108,656
| -16% | -$1.19M | ﹤0.01% | 2037 |
|
|
2020
Q3 | $6.21M | Sell |
690,615
-72,703
| -10% | -$723K | ﹤0.01% | 1902 |
|
|
2020
Q2 | $7.88M | Buy |
763,318
+172,741
| +29% | +$1.77M | ﹤0.01% | 1768 |
|
|
2020
Q1 | $5.96M | Buy |
590,577
+539,820
| +1,064% | +$6.34M | ﹤0.01% | 1783 |
|
|
2019
Q4 | $676K | Sell |
50,757
-633,621
| -93% | -$6.99M | ﹤0.01% | 3144 |
|
|
2019
Q3 | $5.88M | Buy |
+684,378
| New | +$6.65M | ﹤0.01% | 2032 |
|
|
2019
Q2 | – | Sell |
-13,792
| Closed | -$156K | – | 3745 |
|
|
2019
Q1 | $156K | Buy |
13,792
+794
| +6% | +$8.87K | ﹤0.01% | 3653 |
|
|
2018
Q4 | $113K | Sell |
12,998
-555,243
| -98% | -$6.37M | ﹤0.01% | 3638 |
|
|
2018
Q3 | $8.79M | Buy |
+568,241
| New | +$8.98M | ﹤0.01% | 1794 |
|
|
2017
Q3 | – | Sell |
-380,078
| Closed | -$6.01M | – | 3660 |
|
|
2017
Q2 | $6.01M | Buy |
+380,078
| New | +$5.52M | ﹤0.01% | 1836 |
|
|
2015
Q3 | – | Sell |
-5,812
| Closed | -$59K | – | 3882 |
|
|
2015
Q2 | $59K | Buy |
+5,812
| New | +$67.6K | ﹤0.01% | 3958 |
|
|
2013
Q3 | – | Sell |
-3,412
| Closed | -$28K | – | 4322 |
|
|
2013
Q2 | $28K | Buy |
+3,412
| New | +$41.4K | ﹤0.01% | 4099 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Invesco's IRWD Position: Q1 2026 in Review
Invesco increased its Ironwood Pharmaceuticals (IRWD) stake by 22% in Q1 2026, buying an estimated $402K and bringing the position to 547,360 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #2564.
Invesco first reported a position in IRWD in Q2 2013 and has held it in 33 quarters since. The position peaked at $21.1M in Q4 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Invesco held 547,360 shares of Ironwood Pharmaceuticals worth $1.92M as of Q1 2026.
- Invesco bought 98,141 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $402K.
- Ironwood Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2564 holding.
- Invesco first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 33 quarters since.
- Invesco's Ironwood Pharmaceuticals position peaked at $21.1M in Q4 2022.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.